Viewing Study NCT01567059


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-25 @ 4:47 PM
Study NCT ID: NCT01567059
Status: COMPLETED
Last Update Posted: 2017-02-15
First Post: 2012-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor: Fred Hutchinson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module